Drug Discovery and Development

While a new drug usually takes more than 10 years in development before reaching shelves, the Drug Discovery and Development group is working to speed up this process and make new medicines available sooner as part of a major investment in research talent and facilities at the University of South Australia.

Our research

The research programs in Professor Shudong Wang’s group are directed towards the discovery and development of new cancer therapies. A multidisciplinary approach is used for this, where structure-guided and target driven methods are employed in an effort to identify drug candidates and novel therapeutic targets. The blend of extensive capabilities in cutting-edge computational drug design, medicinal chemistry, cellular and animal pharmacology, and toxicology in the single cohesive research group holds the promise for rapid advancement of drug discovery and development.

Ethnobotanical research for the discovery of new medicines from Aboriginal Australia and native plants (lead: Dr Susan Semple)

Read more about our research

Our capabilities

• Computational structure-based and ligand-based drug design (High performance computers, Industry-standard software, etc.)
• Advanced synthetic and medicinal chemistry (Microwave reactors, Purification systems, HPLC, LC/MS/MS, 500MHz 1D and 2D NMR, etc)
• Target-driven biochemical and cell-based assays (Multi-mode reader, Flow cytometer, Auto-western blotting system, etc.)
• ADME/Tox and pharmacology
• Pre-clinical evaluation (state of the art animal facilities, multiple human cancer xenograft models, etc.)

Contact Us

Media enquiries:
Please visit the Media Centre 

All other enquiries:
Professor Shudong Wang 
t - +61 8 8302 2372 
e - Shudong.Wang@unisa.edu.au

Research and Services

Equipment enquiries
Mr Ben Noll
t: +61 8 8302 21601
e: ben.noll@unisa.edu.au

Research collaboration enquiries
Professor Shudong Wang
t: +61 8 8302 2372
e: shudong.wang@unisa.edu.au